The researchers found a new process that makes cellulose-based packaging materials much stronger and more useful in packaging while using less energy than traditional methods. "Natural materials ...

The prevalence of hyperuricemia was higher among patients with rheumatoid arthritis vs the general population. Individuals with rheumatoid arthritis (RA) are more likely to have elevated uric acid ...

New research suggests classical biomarkers cannot discriminate between refractory and non-refractory rheumatoid arthritis. Novel targeted therapies have made a significant impact on the treatment ...

Cedars-Sinai’s center provides personalized, multidisciplinary care for RA and related conditions, improving patient outcomes and quality of life. Dr. Jon Giles' research explores autoimmune ...

Carpal tunnel syndrome (CTS) appeared more than twice as frequently in patients before rheumatoid arthritis (RA) diagnosis than in those without RA, suggesting that CTS could serve as an early ...

Oshy Ellman is an Israeli-born Olah from the United Kingdom and is a Ra’anana resident. She has two decades of experience in international relations and communications and is an active ...

The two most common types, osteoarthritis and rheumatoid arthritis, can both cause joint pain, swelling and stiffness. Both are more common in women. Neither can be cured. But their causes ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Rheumatoid arthritis prevention in patients at the subclinical or pre-clinical stage ...

Whether survival with immune checkpoint inhibitors for cancer is enhanced or diminished for patients with pre-existing rheumatoid arthritis is uncertain. This study used Medicare claims data for ...

Republic Act (RA) 12145, which legislates the DEPDev's charter, was signed by Marcos on April 11, the NEDA said in a statement on Friday. It will take effect 15 days after publication in the Official ...

People with rheumatoid arthritis had the highest death rate - 1.8 deaths per 100,000 among women compared to 0.6 deaths per 100,000 among men throughout the entire study period.

The combination of tofacitinib plus zimlovisertib improved outcomes over tofacitinib alone in patients with rheumatoid arthritis. Ritlecitinib failed to show additive efficacy in rheumatoid ...